Press Releases
Press Releases
Allergan Announces FDA Acceptance of NDA Filing for Oxymetazoline HCI Cream 1.0%
Allergan plc announced that the New Drug Application (NDA) filing for oxymetazoline HCl cream 1.0%, an investigational topical prescription product for the treatment of persistent facial erythema (redness) associated with rosacea in adults, has been accepted by the U.S....
Press Releases
Seqirus receives FDA approval for FLUCELVAX QUADRIVALENT
CSL announced that the US FDA has approved Seqirus’ FLUCELVAX QUADRIVALENT™ (Influenza Vaccine), the first four-strain, cell culture-derived, inactivated seasonal influenza vaccine for people aged four years and older. FLUCELVAX QUADRIVALENT helps protect against the two...
Press Releases
Anti-Cancer Agent vastin ,Obtained Approval for Additional Indication of Advanced or Recurrent Cervical Cancer
Chugai Pharmaceutical Co Ltd announced that it gained approval by the Japanese Ministry of Health, Labour and Welfare (MHLW) on May 23, 2016, for “advanced or recurrent cervical cancer,” as new additional indication for the anti-cancer agent / anti-VEGF...
Press Releases
Astellas Pharma Inc , Daiichi Sankyo, and Takeda Announce Research Collaboration on Establishing Biomarker Database on Healthy Adults
Three Pharmaceutical Companies with Research Bases in Japan Work Together to Accelerate Innovation in Japan-Originated Drug Discovery Astellas Pharma Inc ,Daiichi Sankyo Company, Limited and Takeda Pharmaceutical Company Limited announced that they have entered into a...
Press Releases
Gather China & World Pharmaceutical Entrepreneurs,Create a New Chapter of Chinese Pharma Industry
CPhI& P-MEC China will be held in Shanghai New International Expo Center on June 21-23, 2016.Bearing 15-year trust of the industry, CPhI& P-MEC China continuously lead the development of the Chinese pharmaceuticalindustry, and construct a global one-stop pharmaceutical industrial...
Press Releases
Kyowa Hakko Kirin Announces Commencement of Phase 2 Clinical Study of RTA 402 in CKD patients with type 2 diabetes in Japan
Bardoxolone Methyl (RTA 402) Data Show Improvement in Renal Function by Inulin Clearance in a Phase II Clinical Study in Japan Kyowa Hakko Kirin Co., Ltd. (Tokyo; 4151 President and CEO: Nobuo Hanai; “Kyowa Hakko Kirin”). ...
Press Releases
CHAMPIX European Union Label Updated To Include New Safety And Efficacy Data From The EAGLES Clinical Trial Following Endorsement From CHMP
Pfizer Inc announced that the European Summary of Product Characteristics (SmPC) and Package Leaflet for CHAMPIX® (varenicline) have been updated to include safety and efficacy data from the EAGLES (Evaluating Adverse Events in a Global Smoking Cessation Study) trial....
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read